{"url_path":"/sec/nvno/8-k/2026-07-14/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 ** **Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1661053/0001493152-26-033193-index.html","accession_number":"0001493152-26-033193","cik":"0001661053","ticker":"NVNO","issuer_name":"enVVeno Medical Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1661053/0001493152-26-033193-index.html","primary_entity_key":"0001661053","primary_entity_name":"enVVeno Medical Corp"},"word_count":133,"has_tables":true,"body_markdown":"**Item 7.01** **Regulation FD Disclosure.**\n\n \n\nOn\nJuly 14, 2026, enVVeno Medical Corporation (the “Company”) issued an investor presentation, which may be used by the Company,\nincluding at meetings with investors, analysts or others, in whole or in part and possibly with modifications, from time to time. A copy\nof the investor presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference.\n\n \n\nThe\ninformation contained in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed “filed” for purposes\nof Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any\nfiling under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference\nin such a filing."}